By Kathrin Folkendt News, Pharma, Reproductive Health January 21, 2026 ShareTwitterFacebookPinterest-circled FDA Approves Five-Year Duration of Use for Organon’s Nexplanon Contraceptive Implant
By Kathrin Folkendt Ecosystem, News, Reports January 14, 2026 ShareTwitterFacebookPinterest-circled UN Report: South-East Asia’s Femtech Sector Has More Than Doubled Since 2021, But Funding Gaps Persist
By Kathrin Folkendt Ecosystem, News, Reports January 14, 2026 ShareTwitterFacebookPinterest-circled New Report Finds $100 Billion in Women’s Health Exits Over 25 Years, Challenging “Emerging Market” Narrative
By Kathrin Folkendt Maternal Health, News, Partnership, Pregnancy January 12, 2026 ShareTwitterFacebookPinterest-circled Medicines360 Partners with Wellcome Leap; Licenses Stillbirth Risk Detection Technologies
By Kathrin Folkendt Breast Health, Cancer, Investment, News January 12, 2026 ShareTwitterFacebookPinterest-circled Feminai Raises $6M in Seed Funding for AI-Powered At-Home Breast Cancer Screening
By Kathrin Folkendt Investment, News January 12, 2026 ShareTwitterFacebookPinterest-circled Xella Health Raises $3.7M Pre-Seed for Multi-Omic Women’s Health Testing
By Kathrin Folkendt Chronic Conditions, Consumer Health, Hormonal Health, News January 5, 2026 ShareTwitterFacebookPinterest-circled Parsley Health Launches Lab Review Service; Accepts Results from Function Health, WHOOP, and Others
By Kathrin Folkendt Fertility, Medical Device, News, Regulatory, Reproductive Health December 17, 2025 ShareTwitterFacebookPinterest-circled May Health Receives CE Mark for Anavi System, an In-Office Treatment for PCOS-Related Infertility
